# Novo Nordisk A/S – FDA Inspection, Feb 8, 2017

Source: https://www.keypedia.com/records/fda_inspections/novo-nordisk-as/f7c9c747-d7de-4a6c-9886-e185d08b2706
Source feed: FDA_Inspections

> FDA inspection 1007260 of Novo Nordisk A/S, February 08, 2017. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 8 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1007260
- Company Name: Novo Nordisk A/S
- Inspection Date: 2017-02-08
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1245306 - 2023-03-29
- [FDA Inspection 1165895 - 2019-12-05](https://www.keypedia.com/records/fda_inspections/novo-nordisk-as/1b2e0386-bb32-4a1e-b8c0-6bda25e404ad)
- FDA Inspection 1057438 - 2018-05-18
- FDA Inspection 964462 - 2016-04-08
- [FDA Inspection 846713 - 2013-09-03](https://www.keypedia.com/records/fda_inspections/novo-nordisk-as/d4ee5da4-3a33-41c2-bf98-f33b8e2cca57)

## Related Officers

- Issuing Officer

Company: https://www.keypedia.com/companies/novo-nordisk-as/99c36868-1f84-44c1-8e90-7abc30e92ec3

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d